Search
for
Sort by
Research 151–180 of 1000+
- Tofacitinib Citrate for the Treatment of Nail Dystrophy Associated With Alopecia Universalis
- Mechanisms of autophagy and their implications in dermatological disorders
- Baricitinib for the Treatment of Alopecia Areata
- Integrated single-cell chromatin and transcriptomic analyses of peripheral immune cells in patients with alopecia areata
- Hair Follicle Reconstruction and Stem Cells
- The Role of JAK Inhibitors in Atopic Dermatitis, Alopecia Areata, and Vitiligo: A Review article
- Use of Jak Inhibitors in the Treatment of Alopecia Areata
- The Possible Role of Antibodies in Alopecia: A Narrative Review
- Alopecia Areata and Atopic Dermatitis: Common Mechanisms and Emerging Therapeutics
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology
- Clinical evidence for JAK inhibition in alopecia areata: A comprehensive review
- Systemic Treatment of Moderate to Severe Alopecia Areata in Adults: Updated Australian Expert Consensus Statement
- Considerations for the Treatment Strategy of Relapse After Tofacitinib Therapy in Alopecia Areata
- Modern Management Approaches for Alopecia Areata
- Advances in the mechanism and new therapies of alopecia areata
- An Updated in the Management of Alopecia Areata
- Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients
- JAK-inhibitors. New players in the field of immune-mediated diseases, beyond rheumatoid arthritis
- Alopecia areata
- Rapid skin repigmentation on oral ruxolitinib in a patient with coexistent vitiligo and alopecia areata (AA)
- Leptin and the skin: a new frontier
- Topical Ruxolitinib for the Treatment of Alopecia Universalis
- Alopecia areata: Animal models illuminate autoimmune pathogenesis and novel immunotherapeutic strategies
- Tofacitinib for the treatment of lichen planopilaris: A case series
- Treatment of an alopecia areata patient with tofacitinib results in regrowth of hair and changes in serum and skin biomarkers
- Vitiligo: An Autoimmune Skin Disease and its Immunomodulatory Therapeutic Intervention
- Netherton syndrome subtypes share IL-17/IL-36 signature with distinct IFN-α and allergic responses
- JAK inhibitors and alopecia areata
- Functional Interpretation of Genome-Wide Association Study Evidence in Alopecia Areata
- Experience with oral tofacitinib in 8 adolescent patients with alopecia universalis